CLINICAL_TRIALS
research
· 2026-03-11
Clinical Trial Update: WBSI Guided Personalized Delivery of TTFields [NA]
Summary
This clinical trials entry reports that a Penn Medicine Abramson Cancer Center study evaluating WBSI-guided, personalized delivery of tumor-treating fields (TTF…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: GBM, Glioma Glioblastoma Multiforme | NA | Status: RECRUITING